Group 1 - The core viewpoint of the article is that the company, Up Beauty Co., is expected to achieve impressive financial performance in 2025, with significant revenue and profit growth driven by its multi-brand and multi-category strategy [4][5] Group 2 - In 2025, the company anticipates revenue between 9.1 billion to 9.2 billion yuan, representing a year-on-year increase of 34.0% to 35.4%, and a net profit of 1.14 billion to 1.16 billion yuan, reflecting a year-on-year increase of 41.9% to 44.4% [4] - For the first half of 2025, the company expects to achieve revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, a year-on-year increase of 34.7% [4] - In the second half of 2025, the company projects revenue of 5.04 billion yuan, a year-on-year increase of 53.2%, and a net profit of 590 million yuan, a year-on-year increase of 52.1% [4] Group 3 - The company's strong performance is attributed to the successful layout of multiple brands and categories, with notable growth in the scientific anti-aging skincare brand Han Shu and the infant and child skincare brand Newpage [5] - According to third-party platform data, Han Shu's sales on Taobao and Douyin increased by 26% and 13% respectively, while Newpage's sales grew by 82% and 166% [5] - The company is optimizing its channel structure and enriching its product offerings, with Han Shu's channel structure becoming healthier and its product mix becoming more balanced [5]

Investment Rating - The report maintains a "Buy" rating for the company [3][5] Core Insights - The company is expected to achieve a revenue of 9.1 to 9.2 billion yuan in 2025, representing a year-on-year increase of 34.0% to 35.4%, with net profit projected at 1.14 to 1.16 billion yuan, an increase of 41.9% to 44.4% [1][3] - The strong performance is attributed to the successful multi-brand and multi-category strategy, with notable growth in the skincare brand Han Shu and the children's skincare brand Newpage [2][3] - The company is optimizing its channel structure and diversifying its product offerings, leading to a healthier sales channel for Han Shu and significant growth in Newpage's customer demographics [2][3] Financial Projections - The projected revenue and net profit for 2025 are 9.15 billion yuan and 1.16 billion yuan respectively, with earnings per share (EPS) expected to be 2.91 yuan [3][10] - The company anticipates continued growth with net profits projected at 1.45 billion yuan and 1.82 billion yuan for 2026 and 2027 respectively, with corresponding EPS of 3.65 yuan and 4.57 yuan [3][10] - The price-to-earnings (P/E) ratio is expected to be 18, 15, and 12 for the years 2025, 2026, and 2027 respectively [3][10] Brand Performance - Han Shu's sales on platforms like Taobao and Douyin have increased by 26% and 13% respectively, while Newpage's sales have surged by 82% and 166% on the same platforms [2] - The company is expanding its product categories, with a focus on men's skincare, makeup, body care, and hair care, while Newpage is broadening its target age group to 6-18 years [2][3]

Core Viewpoint - The recent controversy surrounding the ingredient EGF in the core brand Han Shu of Shangmei Co. has led to significant stock price fluctuations and raised concerns about the company's future growth plans [4][5][8]. Group 1: Company Developments - Chairman Lv Yixiong announced that executive director Luo Yan purchased 364,000 shares at approximately HKD 75.5 each, totaling about HKD 66.32 million, indicating strong confidence in the company's future [2]. - The company aims to achieve a revenue target of 30 billion yuan by 2030, requiring a doubling of current revenue within five years [12][38]. - In the first half of the year, the company's revenue reached 4.1 billion yuan, with a goal of hitting 10 billion yuan in annual revenue for the new brand Newpage [11][22]. Group 2: Controversy and Market Reaction - The controversy originated from the detection of EGF in two Han Shu face masks, leading to a significant drop in stock price, with a loss of over 10 billion yuan in market value [5][8]. - Han Shu's official response included presenting third-party testing results to refute the claims, but investor concerns persisted, resulting in a 30% drop in stock price on the first trading day after the holiday [8][39]. - The Chinese Fragrance and Cosmetic Industry Association noted that there is currently no commercial ELISA kit available for testing EGF in cosmetics, which complicates the situation [9]. Group 3: Strategic Expansion Plans - The company is in a critical expansion phase, planning to launch 20 new brands between 2025 and 2027, primarily leveraging the Douyin platform for marketing [10][22]. - The company is also focusing on international markets, with a significant investment of 300 million yuan in a factory in Southeast Asia [24]. - The strategy includes hiring top talent and implementing a rigorous selection process to enhance brand development and marketing effectiveness [29][32].

Core Viewpoint - Up Beauty Co., Ltd. has achieved a year-to-date increase of over 150%, significantly outperforming its peers in the Hong Kong "new consumption" sector, indicating strong market confidence in the company's multi-brand and multi-category growth strategy [1][2]. Group 1: Multi-Brand Development - Up Beauty has successfully transitioned from a "single brand dependency" to a "multi-brand co-development" model, with its second-tier brands gaining momentum and contributing to overall growth [2]. - Han Shu, the leading brand, reported a revenue of 3.344 billion yuan in the first half of the year, marking a 14.3% year-on-year increase, and dominated multiple beauty rankings during the Double 11 shopping festival [2]. Group 2: Strong Performance of New Brands - The brand "Yi Ye" has emerged as a core growth driver, achieving a revenue of 397 million yuan in the first half of the year, a substantial increase of 146.5%, and a 145% year-on-year growth during Double 11 [3]. - Yi Ye's repurchase rate exceeds 50%, indicating strong customer loyalty and market presence, supported by successful product launches like the Baby Comfort Cream [3]. Group 3: Breakthroughs in New Brands - New brands such as An Min You and Ji Fang have shown remarkable growth, with An Min You's GMV reaching approximately 20 million yuan in August and a 208% year-on-year increase during Double 11 [4]. - Ji Fang's sales also surged, achieving a 302% increase in total sales during Double 11 compared to the previous month [5]. Group 4: Multi-Category Expansion - Up Beauty is strategically expanding into multiple categories, capturing diverse consumer demands and enhancing growth potential [6]. - Han Shu has made significant inroads into various segments, including men's skincare and high-end hair care, with sales exceeding 100 million yuan in ten subcategories [6]. Group 5: Multi-Channel Growth - The company has successfully diversified its sales channels, breaking previous concerns about reliance on a single platform, with strong performances across platforms like Douyin, Tmall, and JD during Double 11 [9][10]. - Han Shu achieved top rankings across multiple platforms, while other brands also experienced balanced growth, indicating a robust multi-channel strategy [9][10]. Group 6: Strengthening R&D Capabilities - Up Beauty is enhancing its core R&D capabilities by integrating top-tier scientific resources, including the appointment of Dr. Karl Lintner as Chief Scientific Advisor [11][12]. - The establishment of a joint laboratory with China Pharmaceutical University aims to accelerate the translation of research into market-ready products, enhancing the company's competitive edge in skincare innovation [13].

Core Viewpoint - The company is experiencing increased growth certainty, allowing for a valuation premium, driven by better-than-expected performance growth, particularly in its main brand, Han Shu, which has successfully identified new revenue sources and adjusted operational strategies [1][2]. Group 1: Company Performance - Han Shu achieved revenue of 3.34 billion yuan in the first half of 2025, representing a year-on-year growth of 14% [1]. - The company has shifted its operational strategy, reducing the proportion of live streaming sales, resulting in a decrease in sales expense ratio by 0.7 percentage points year-on-year in the first half of 2025 [1]. - The company has seen explosive revenue growth in 2023 and 2024, with year-on-year increases of 144% and 81%, respectively [2]. Group 2: Brand Strategy - The "All in" strategy on Douyin has allowed Han Shu to break through and achieve significant sales growth, leveraging historical experience and rapid decision-making by the founder [2]. - The company is adopting a "top-tier resources" approach to create new brands, ensuring they have attention and differentiation from the outset, as demonstrated by the successful new brand "newpage," which generated 400 million yuan in revenue in the first half of 2025, a year-on-year increase of 146% [3]. - The company is expanding its brand portfolio with multiple new brands across different categories, which is expected to further validate its operational capabilities and enhance long-term growth certainty [3]. Group 3: Financial Projections - The company has adjusted its profit forecasts, expecting net profits of 1.07 billion, 1.33 billion, and 1.59 billion yuan for 2025 to 2027, representing year-on-year growth rates of 37.2%, 24.0%, and 20.0%, respectively [3]. - The price-to-earnings ratio (PE) is projected to be 33, 26, and 22 times for 2025, 2026, and 2027, respectively, based on the closing price on October 17, 2025 [3].

Core Viewpoint - The company reported strong financial performance in H1 2025, with revenue of 4.108 billion yuan, a year-on-year increase of 17.3%, and a net profit of 556 million yuan, up 34.7% [1][2]. Group 1: Financial Performance - Revenue breakdown by brand shows that Han Shu generated 3.344 billion yuan, accounting for 81.4% of total revenue, with a year-on-year growth of 14.3% [1]. - Newpage achieved revenue of 397 million yuan, a significant increase of 146.5%, representing 9.6% of total revenue, driven by strong sales of its star products [1]. - One Leaf reported revenue of 89 million yuan, a decline of 29.0%, making up 2.2% of total revenue due to transformation adjustments [1]. - Red Little Elephant generated 159 million yuan, down 8.7%, accounting for 3.9% of total revenue, with a narrowing decline as brand strength improves [1]. Group 2: Strategic Initiatives - The company is implementing a "Six Six Strategy" focusing on six major sectors: mass skincare, maternal & child care, personal care, color cosmetics, functional skincare, and high-end skincare, aiming for sustainable development [2]. - The company’s gross margin decreased by 1.0 percentage points to 75.5%, while the net profit margin increased by 1.7 percentage points to 13.5%, indicating improved profitability [2]. - Sales expense ratio decreased by 0.7 percentage points to 56.9%, reflecting the release of scale effects [2]. Group 3: Future Outlook - The company forecasts net profits of 1.02 billion yuan, 1.28 billion yuan, and 1.55 billion yuan for 2025-2027, with year-on-year growth rates of 31.1%, 25.3%, and 20.9% respectively [2]. - The strong performance of the main brand Han Shu on Douyin has established significant brand momentum, with potential for other brands to replicate this success [2].

Group 1 - The core viewpoint of the news is that Shangmei Co., Ltd. reported strong financial performance for the first half of 2025, with significant revenue and profit growth, leading to a rise in stock price [1] - For the six months ending June 30, 2025, the company achieved a revenue of 4.108 billion yuan, a year-on-year increase of 17.29%, and a net profit attributable to shareholders of 524 million yuan, up 30.65% year-on-year [1] - The company plans to distribute an interim dividend of 0.5 yuan per share [1] Group 2 - The revenue from the Han Shu brand for the first half of 2025 was 3.344 billion yuan, an increase of 14.3% compared to 2.927 billion yuan in the first half of 2024, driven by brand upgrades and category expansion [1] - Han Shu maintained its leading position in the online beauty industry, ranking first in total gross merchandise value (GMV) on the Douyin platform and achieving the top spot in the "Douyin E-commerce Skincare Brand Overall Ranking H1" [1] - According to Haitong International, other brands under the company, such as Newpage, Yiyue, and Red Little Elephant, reported revenues of 397 million, 89 million, and 159 million yuan respectively, with Newpage showing a significant year-on-year growth of 146.5% [2]

Group 1 - The core viewpoint of the news is that 上美股份 (Shangmei Co., Ltd.) has shown significant growth in its mid-term performance for the first half of 2025, with a revenue increase of 17.29% year-on-year and a notable rise in shareholder profit by 30.65% [1] - For the first half of 2025, 韩束 (Hansu) contributed 33.44 billion yuan in revenue, up 14.3% from 29.27 billion yuan in the same period of 2024, driven by brand upgrades and category expansion [1] - 韩束 maintained its leading position in the online beauty industry, achieving the highest monthly GMV among beauty brands on the Douyin platform and ranking first in the "Douyin e-commerce skincare brand total list H1" [1] Group 2 - 海通国际 (Haitong International) reported that besides the 韩束 brand, the new brands newpage, 一叶子 (Yiyezi), and 红色小象 (Red Elephant) generated revenues of 3.97 billion, 0.89 billion, and 1.59 billion yuan respectively, with year-on-year changes of +146.5%, -29.0%, and -8.7% [2] - The revenue contribution from newpage increased by 5 percentage points year-on-year, making it the second-largest revenue contributor [2] - The repurchase rates for newpage on Tmall and Douyin were 54% and 53% respectively, showing increases of 6% and 16% year-on-year, with an average transaction value of approximately 130 yuan [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company has shown impressive performance in H1 2025, with revenue reaching 4.108 billion RMB, a year-on-year increase of 17.3%, and a net profit of 556 million RMB, up 34.7% year-on-year [8] - The multi-brand strategy is effectively driving revenue growth, with the main brand, 韩束 (Han Shu), generating 3.344 billion RMB in revenue, a 14.3% increase, and maintaining a leading position in online beauty sales [8] - The company is implementing a "Six Six Strategy" to focus on six major segments, aiming for sustainable development and expanding its business boundaries [8] - The net profit margin has improved, with a net profit margin of 13.5% in H1 2025, an increase of 1.7 percentage points year-on-year [8] - Future earnings forecasts indicate a strong growth trajectory, with expected net profits of 1.024 billion RMB in 2025, representing a 31.1% year-on-year increase [9] Financial Summary - Revenue projections for 2025 are estimated at 8.679 billion RMB, with a growth rate of 27.8% [7] - The company’s gross margin is projected to be 76.8% in 2025, reflecting a slight increase from previous years [9] - The return on equity (ROE) is expected to be 31.8% in 2025, indicating strong profitability [7]

Core Insights - The beauty industry in China is experiencing a significant performance divergence among leading companies, with a notable emphasis on quality improvement amidst a deep industry adjustment [1][2]. Group 1: Industry Performance - In the first half of 2025, retail sales of cosmetics in China increased by 2.9% year-on-year, with domestic brands capturing over 55% market share [2]. - Exports of cosmetics surged by 12% to 25.8 billion yuan, indicating strong overseas growth potential [2]. Group 2: Leading Companies - Leading companies like Proya, Mao Geping, and Shangmei continue to excel, while others like Huaxi Biological and Fulejia are lagging behind [2]. - Proya reported revenue of 5.362 billion yuan, a 7.21% increase, and a net profit of 799 million yuan, up 13.8% [4]. - Mao Geping achieved a revenue of 2.588 billion yuan, with a remarkable growth rate of 31.3%, and a net profit of 670 million yuan, reflecting a 36.1% increase [5]. - Shangmei's revenue reached 4.108 billion yuan, growing by 17.3%, with a net profit of 556 million yuan, up 34.7% [5]. - Juzhi Biological reported revenue of 3.113 billion yuan, a 22.5% increase, and a net profit of 1.182 billion yuan, up 20.2% [5]. Group 3: Underperforming Companies - Huaxi Biological reported a significant decline, with revenue dropping nearly 19.57% to 2.261 billion yuan and net profit falling 35.38% to 221 million yuan [6]. - Fulejia's revenue decreased by 8.15% to 863 million yuan, with a net profit decline of 32.54% to 230 million yuan, largely due to increased marketing expenses [9][11]. Group 4: Second-Tier Companies - Second-tier companies like Shanghai Jahwa, Marubi, and Shuiyang are showing improved performance [13]. - Shanghai Jahwa's revenue was 3.478 billion yuan, up 4.8%, with a net profit of 270 million yuan, increasing by 11.7% [14]. - Marubi achieved revenue of 1.769 billion yuan, a 30.83% increase, but net profit growth was only 5.21% [14]. - Shuiyang reported revenue of 2.5 billion yuan, a 9.02% increase, and a net profit of 123 million yuan, up 16.54% [14].